UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Clinical trial NCT07349212 · RECRUITING

Trial details

NCT number: NCT07349212
Sponsor: Ukko Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peanut-Induced Anaphylaxis Peanut Allergy

Start date: 2026-02-18
Primary completion: 2027-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.